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Binding of about 1 mol of adenosine triphosphopyridoxal to Escherichia coli F,-ATPase resulted in the nearly complete 
inactivation of the enzyme [(1987) J. Biol. Chem. 262, 768676921. About two thirds of the label was bound to the 
a-subunit, and the rest to the p-subunit. The present study revealed that LysZo’ in the a-subunit and L~s’*~ in the glycine- 
rich region of the B-subunit are the major sites labeled with this reagent. Thus, these two residues might be located close 
to the y-phosphate of the bound ATP. 
F,-ATPase; Nucleotide-binding site; Affinity label; Adenosine polyphosphopyridoxal; Glycine-rich region 
1. INTRODUCTION 
Escherichia coli H+-ATPase catalyzes ATP syn- 
thesis from ADP and inorganic orthophosphate 
coupled with an electrochemical gradient of pro- 
tons. The catalytic portion of the enzyme, F1, has 
a structure of cy&y& and contains six nucleotide- 
binding sites; three nonexchangeable (non- 
catalytic) and three exchangeable (catalytic) sites 
[l-3]. Several lines of evidence indicate that both 
LY- and P-subunits contain nucleotide-binding sites 
[4-61. A photoaffinity cross-linking study showed 
the presence of nucleotide-binding sites at the in- 
terface between the LY- and &subunits [7]. Cross et 
al. [8] suggested that the catalytic and noncatalytic 
sites are located in the P-subunit and at the inter- 
face between the LY- and &subunits, respectively. 
We previously showed that the binding of about 
1 mol of AP3-PL to 1 mol of E. coli Fl-ATPase 
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caused nearly complete inactivation of the enzyme 
[9]. About two-thirds of APs-PL was bound to the 
a-subunit, and the rest to the P-subunit. The 
kinetic studies of inactivation provided evidence 
that the reagent binds to the catalytic sites of the 
enzyme [9]. The results of the present study 
demonstrate that Lys201 in the a-subunit and 
Ly? in the P-subunit are predominantly labeled 
with AP3-PL. The latter residue is located in the 
glycine-rich region which is often observed in 
nucleotide-binding proteins [ 10,111. 
2. EXPERIMENTAL 
AP,-PL was synthesized according to the method of Tagaya 
and Fukui [12]. Asahipak ODP (6 x 150 mm) and Synchropak 
RP-P (4.1 x 250 mm) were obtained from Asahi Kasei Co. and 
M&S Instruments, respectively. Lysyl endopeptidase was ob- 
tained from Wako Chemical. Other proteases used in this study 
were purchased from Worthington. 
ATP-hydrolyzing activity was assayed at 37°C in 50 mM 
Tris-HCI (pH 8.0) containing 4.0 mM ATP, 2.0 mM MgClz, 
and an appropriate amount of the enzyme. ITP-hydrolyzing ac- 
tivity was measured using 2.0 mM ITP and 1.0 mM MgClz 
under similar conditions. 
AP3-PL-labeled peptides were purified as follows. About 90 
mg of E. coli FL-ATPase (70 ml) which had been passed through 
a column (1.6 x 90 cm) of Sephadex G-50 (coarse) equilibrated 
with 50 mM 3-(N-morpholino)propanesulfonic acid (pH 8.0) 
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was incubated with 0.1 mM APs-PL at 25°C for 40 min. To this 
solution was added 1.4 ml of a freshly prepared 0.1 M NaBH4 
solution, and the mixture was left to stand for 20 min. The 
modified enzyme was dialyzed against 0.5 M Tris-HCl (pH 8.6) 
containing 13 mM EDTA, and carboxymethylated as described 
by Reimann et al. [13]. The carboxymethylated protein was 
dialyzed against water, and lyophilized. The lyophilized 
materials were dissolved in 2 ml of 0.1 M Tris-HCl (pH 9.0) 
containing 8 M urea, and then diluted with 2 ml of 0.1 M Tris- 
HCl (pH 9.0). The protein was digested at 37°C for 6 h with 
lysyl endopeptidase in the ratio of protein to protease of 100: 1. 
The digest was applied to a column (2.3 x 170 cm) of Sephadex 
G-50 (super fine) equilibrated with 0.2 M NHdHCOs-NHdOH 
(pH 9.0), and 3.0-ml fractions were collected. Fractions 
112-123 and 147-157 were separately pooled, and lyophilized. 
Fractions 112-123 (peak II): the lyophilized fragments 
dissolved in 1 ml of 0.1 M Tris-HCl (pH 8.0) were incubated 
with 20 pg of Stuphylococcus V8 protease at 37°C overnight. 
The digest was applied to a column (2.8 x 90 cm) of Bio-Gel P-6 
equilibrated with 0.2 M NHdHCOs-NH40H (pH 9.0), and 
2.4-ml fractions were collected. The fluorescent material eluted 
as a single peak was pooled, lyophilized, and dissolved in 1 ml 
of 1 mM NaOH. A portion of the solution was subjected to 
HPLC with Asahipak ODP at a flow rate of 0.75 ml/min. The 
solvents used were (A) 20 mM NHdOH-CHsCOOH (pH 9.0) 
and (B) 20 mM NHdOH-CHsCOOH (pH 9.0) containing 80% 
acetonitrile. Gradients were run as follows: time O-80 min, a 
linear gradient of(B) from O-40%; 85-90 min, linear gradient 
of (B) from 40-90%. 
Fractions 147-157 (peak IV): the lyophilized fragments 
dissolved in 0.1 M NHdHCOs were incubated with 25 pg of 
trypsin at 37°C for 6 h. The digest was applied to a column 
(2.8x90 cm) of Bio-Gel P-6 equilibrated with 0.1 M 
NH4HCO,-NH40H (pH 9.0), and 2.2-ml fractions were col- 
lected. The fluorescent material eluted as a single peak was 
pooled and lyophilized. The lyophilized material was dissolved 
in 1 ml of 0.1 M NHeHCO3, and a portion of the solution (0.1 
ml) was further digested with 25pg of chymotrypsin at 37°C for 
AP3-PL (JJM) 
Fig. 1. Comparison of the inactivation of the ATP- and ITP- 
hydrolyzing activities of Ft-ATPase by AP3-PL. E. co/i 
Fr-ATPase was incubated with APs-PL at various 
concentrations (4-100 PM) at 25°C in 50 mM 3-(N- 
morpholino)propanesulfonic acid (pH 8.0). After 30 min, 
NaBH., was added to a final concentration of 2 mM to fix the 
inhibitor, and then ATP- (0) and ITP- (A) hydrolyzing 
activities were measured. 
10 h. The digest was applied to HPLC with Synchropak RP-P 
at a flow rate of 0.75 ml/min. The solvents used were (A) 0.1% 
trifluoroacetic acid containing 5% acetonitrile and (B) 0.1% 
trifluoroacetic acid containing 90% acetonitrile. Gradients were 
run as follows: time O-10 min, buffer (B) 0%; time lo-70 min, 
a linear gradient of buffer (B) from O-30%; time 70-75 min, a 
linear gradient of buffer (B) from 30-90%. The labeled peptides 
were purified by rechromatography with the same column 
under the following conditions. The solvents were (A) 10 mM 
CH3COONH4 and (B) 10 mM CHsCOONH4 containing 90% 
acetonitrile. Gradients were run as follows: time O-40 min, a 
linear gradient of buffer (B) from O-15%; time 40-45 min, a 
linear gradient of buffer (B) from 15-90%. 
3. RESULTS 
Previous results suggested that AP3-PL binds to 
the catalytic sites of Fi-ATPase 191. A further 
criterion for the binding to the catalytic sites is the 
same sensitivity of ATP- and ITP-hydrolyzing ac- 
tivities of the enzyme to the reagent (cf. 14,151. 
When ATP- and ITP-hydrolyzing activities were 
measured after modification of the Fi-ATPase 
with various concentrations of AP3-PL, both ac- 
tivities were inhibited to the same degree (fig.l), 
supporting the binding of APs-PL to the catalytic 
sites. 
APs-PL-labeled E. coli Fr-ATPase was digested 
with lysyl endopeptidase, and a mixture of 
fragments were applied to a Sephadex G-50 col- 
umn (fig.2). Fluorescence due to the pyridoxyl 
moiety of the label was eluted as four peaks. The 
first fluorescent peak (peak I) was eluted at a posi- 
tion corresponding to the void volume of the col- 
04, !a0 I 
I20 160 200 
FRACTION NUMBER 
Fig.2. Gel filtration of AP3-PL-labeled Fr-ATPase after 
digestion with lysyl endopeptidase. Details are described in 
section 2. 
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TlME(min) 
umn, suggesting that peak I is the undigested 
material. The amount of fluorescence in peak III 
was much smaller than those of peaks II and IV. 
In the preliminary experiment using a small 
amount of Fi-ATPase labeled with [3H]AP3-PL, 
only two radioactive peaks corresponding to peak 
II and IV were observed (data not shown). 
Therefore, peak III may be an incompletely cleav- 
ed peptide or nonspecifically labeled peptide( 
We did not further analyze peaks I and III. 
Fig.3. HPLC of APs-PL-labeled peptides. The elution patterns 
of Stuphylococcus V8 protease-digested peptides of peak II (a) 
and trypsin-digested peptides of peak IV (b). Rechromatog- 
raphy of the fluorescent material in the trypsin-digested 
neotides of oeak IV (c). Arrows indicate the Desks with 
The peptide mixture in peak II was digested with 
Staphylococcus V8 protease, and the labeled pep- 
tide was purified by a combination of Bio-Gel P-6 
gel chromatography and HPLC under alkaline 
conditions. In each purification step, essentially 
only one fluorescent peak was observed. As shown 
in fig.3a, a fluorescent peptide was eluted at 61 
min on HPLC with 45% yield. Sequence analysis 
(table 1) showed that this peptide corresponds to a 
segment from Va1’45 to C&r161 in the P-subunit of 
Fr-ATpase [ 161. No phenylthiohydantoin deriva- 
tive of amino acid was detectable at cycle 11. We 
surmise from the known sequence of the P-subunit 
[16] that the 11th amino acid is a labeled lysine _ . 
fluorescence. De&s are described in section 2. (Lys”‘). 
Table 1 
Amino acid sequences of APj-PL-labeled peptides 
Peak II Peak IV 
Major Minor 
Cycle Amino Yield 
no. acid (pmol) 
Cycle Amino Yield Cycle Amino Yield 
no. acid (pmol) no. acid (pmol) 
1 Val 
2 Gly 
3 Leu 
4 Phe 
5 GlY 
6 Gly 
7 Ala 
8 Gly 
9 Val 
10 GlY 
11 N.I. 
12 Thr 
13 Val 
14 Asn 
15 Met 
16 Met 
17 GlU 
870 
410 
280 
210 
220 
200 
230 
160 
150 
130 
_ 
81 
76 
89 
94 
8 
1 Val 
2 Ala 
3 Ile 
4 GlY 
5 Gln 
6 N.I.a 
I Ala 
8 Ser 
9 N.I. 
10 Ile 
110 
100 
75 
71 
53 
60 
_ 
23 
1 Val 
2 Ala 
3 Ile 
4 GlY 
5 Gln 
6 N.I. 
7 Ala 
8 Ser 
28 
30 
36 
31 
39 
23 
- 
a Not identified 
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The peptide mixture in peak IV was digested 
with trypsin, and only one fluorescent peak was 
observed on Bio-Gel P-6 chromatography. The 
fluorescent fractions were pooled, lyophilized, and 
then digested with chymotrypsin. Chymotryptic 
fragments were applied to HPLC and eluted with 
trifluoroacetic acid. Fluorescent materials were 
eluted at 30 min as a broad peak with 70% 
recovery (fig.3b). The peak material was applied to 
the same column and eluted with ammonium 
acetate (fig.3c). Two fluorescent peptides were 
eluted at 26 and 32 min in the fluorescence ratio of 
approx. 3 : 1. Sequence analyses (table 1) showed 
that the structures of the two peptides are the same 
and correspond to a segment from Va1196 to Ile *05 
in the cy subunit [16]. No phenylthiohydantoin 
derivative of amino acid was detectable at cycle 6. 
We surmise that the 6th amino acid is a labeled 
lysine (Lys*Ol). 
4. DISCUSSION 
The results of the present study demonstrate that 
Lys?’ in the m-subunit and Lysls5 in the P-subunit 
are the major sites labeled with APx-PL. These 
residues are completely conserved in all the known 
sequences of Fr-ATPases except that Lyszo’ in the 
a-subunit is conservatively substituted by arginyl 
residue in the wheat chloroplast enzyme [17]. Fur- 
thermore, the regions in their vicinities, especially 
around Lysi5’ in the &subunit, are highly con- 
served, consistent with the idea that these residues 
play important roles in enzyme catalysis. 
Bullough and Allison [14,15] showed that the 
complete inactivation of bovine Fr-ATPase is ac- 
companied by the incorporation of 1 mol of FSBI 
per mol of enzyme, whereas the binding of 3 mol 
of FSBA per mol of enzyme is necessary for the 
complete inactivation. Since the noncatalytic sites 
are highly specific for adenine nucleotides [ 181, 
they suggested that FSBI and FSBA bind to the 
catalytic and noncatalytic sites, respectively. This 
suggestion was confirmed by the finding that 1 mol 
of 2-azido ATP binds to the catalytic sites per mol 
of Fr and modifies the same tyrosyl residue as 
FSBI [8]. Thus, the binding of 1 mol of an adenine 
nucleotide analogue to the catalytic sites might be 
enough for the complete inactivation. Our 
previous study revealed that binding of 1 mol of 
AP3-PL per mol of enzyme resulted in nearly com- 
350 
plete inactivation [9]. In accordance with the 
binding of FSBI to the catalytic sites, both ATP- 
and ITP-hydrolyzing activities decreased at the 
same rate [ 151. Similarly, both activities showed 
the same sensitivities to AP3-PL (fig.l). Based on 
the present findings and the detailed kinetic 
analysis [9], we conclude that AP3-PL binds to the 
catalytic sites of the enzyme. Kironde and Cross 
[19] discussed the location of the catalytic and non- 
catalytic sites in Fi-ATPase, and proposed several 
models. However, the evidence accumulated is still 
not enough to conclude exclusively which model is 
correct. Since the possibility that both cy- and ,& 
subunits have independent catalytic sites is unlike- 
ly, our results are consistent with the model that 
the catalytic sites are located at the interface be- 
tween the a- and ,& subunits [7]. 
4-Chloro-7-nitrobenzofurazan also modified 
Lys’55 in the P-subunit [20], which is within the 
conserved sequence [Gly-X-X-X-X-Gly-Lys- 
Ser(Thr)] of nucleotide-binding proteins such as 
adenylate kinase [lO,ll]. The analysis of the mu- 
tant enzyme [21] and the results of site-directed 
mutagenesis studies [22,23] suggested the impor- 
tance of the conserved sequence and LYS’~~ for en- 
zyme activity. It is generally assumed that the lysyl 
residue in this region is located close to the y- 
phosphate of the bound ATP on analogy of 
adenylate kinase, of which three-dimensional 
structure was resolved [24]. However, the exact 
location of the nucleotide-binding sites in 
adenylate kinase could not be concluded from 
physical studies [11,25]. We have recently 
demonstrated that AP3-PL binds to Lys*‘, located 
in the conserved sequence, and suggested that the 
E-amino group of Lys*’ is in the vicinity of the y- 
phosphate of the bound ATP [26,27]. The present 
study provided the evidence that Lysls5 in the ,& 
subunit of Fi-ATPase is also located close to the y- 
phosphate of the bound ATP. 
In addition to Lys”’ in the P-subunit, Lys201 in 
the a-subunit might also be located close to the y- 
phosphate of the bound ATP. Since both subunits 
show considerable sequence homology [ 16,171, it 
would be expected that their secondary and tertiary 
structures are similar. However, AP3-PL did not 
bind to LYS”~ in the a-subunit, a lysyl residue cor- 
responding to Lys ls5 in the P-subunit, suggesting 
that the residues involved in the binding of 
nucleotides are different from each other in the 
Volume 233, number 2 FEBS LETTERS June 1988 
two subunits. Based on the prediction of the secon- 
dary structure, Lys”’ in the P-subunit seems to be 
located in a loop between an a-helix and a ,&- 
structure [28]. Lys201 in the a-subunit is also ex- 
pected to be located at a turn between an a-helix 
and a p-structure [29]. The locations of the two 
lysyl residues are reasonable because adenine 
nucleotides generally bind to the edge of au/p 
folding (‘Rossmann fold’, review [30]). Yamamoto 
et al. [31] have recently shown that AP,-PL binds 
to Lys6s4 in sarcoplasmic reticulum Ca2+-ATPase. 
However, no sequence homology was observed in 
the AP3-PL-labeled region between Fr-ATPase 
and Ca2+-ATPase. 
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